Illumina's Billion Cell Atlas Aims to Speed Drug Discovery with AI-powered Insights
Illumina unveiled the Billion Cell Atlas, a massive dataset mapping how gene perturbations affect 200 cell lines to accelerate drug discovery via AI-powered models and virtual cells; with about 150 million cells generated so far and a goal of a billion by year-end, the company has signed on Merck, AstraZeneca, and Eli Lilly as initial customers.